RINALDI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 2.394
EU - Europa 836
AS - Asia 790
SA - Sud America 134
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.245
Nazione #
US - Stati Uniti d'America 2.364
SG - Singapore 278
VN - Vietnam 169
RU - Federazione Russa 143
CN - Cina 135
IT - Italia 134
BR - Brasile 114
DE - Germania 89
UA - Ucraina 87
IE - Irlanda 80
SE - Svezia 78
HK - Hong Kong 67
CI - Costa d'Avorio 62
FI - Finlandia 59
FR - Francia 49
TR - Turchia 42
GB - Regno Unito 41
IN - India 31
DK - Danimarca 24
CA - Canada 18
PL - Polonia 18
BD - Bangladesh 14
KR - Corea 14
NL - Olanda 12
AR - Argentina 10
JP - Giappone 10
MA - Marocco 10
ZA - Sudafrica 10
IQ - Iraq 6
ES - Italia 5
LT - Lituania 5
MX - Messico 5
AZ - Azerbaigian 3
BE - Belgio 3
CO - Colombia 3
ID - Indonesia 3
IL - Israele 3
KE - Kenya 3
PK - Pakistan 3
UZ - Uzbekistan 3
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
JM - Giamaica 2
MY - Malesia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
SA - Arabia Saudita 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.245
Città #
Ashburn 425
Chandler 236
Singapore 199
Fairfield 168
Jacksonville 135
Dublin 80
Seattle 79
San Jose 78
New York 76
Wilmington 73
Houston 70
Hong Kong 67
Woodbridge 67
Boardman 65
Abidjan 62
Los Angeles 62
Dallas 57
Des Moines 57
Ho Chi Minh City 57
Cambridge 50
Beijing 40
Hanoi 39
Munich 39
The Dalles 37
Turku 34
Ann Arbor 31
Lawrence 30
Princeton 30
Lauterbourg 29
San Mateo 29
Moscow 24
Turin 21
Washington 18
Milan 17
Buffalo 16
Warsaw 16
São Paulo 15
Helsinki 14
Chicago 13
Orem 13
San Diego 13
Santa Clara 13
Chennai 12
Da Nang 11
Montreal 11
London 10
Poplar 10
Brooklyn 9
Rio de Janeiro 9
Tokyo 9
Hefei 8
Johannesburg 8
Norwalk 8
Phoenix 8
Shanghai 8
Amsterdam 7
Columbus 7
Denver 7
Haiphong 7
Ancona 6
Atlanta 6
Pune 6
Ankara 5
Boston 5
Falls Church 5
Miano 5
Rome 5
Saint Louis 5
Baghdad 4
Bến Tre 4
Council Bluffs 4
Frankfurt am Main 4
Baku 3
Can Tho 3
Castelraimondo 3
Charlotte 3
Cleveland 3
Guangzhou 3
Jiaxing 3
Kilburn 3
Maceió 3
Miami 3
Montegiorgio 3
Nairobi 3
Stockholm 3
Tampa 3
Tashkent 3
Toronto 3
Vũng Tàu 3
Wuhan 3
Anápolis 2
Bengaluru 2
Brussels 2
Casablanca 2
Chengdu 2
City of London 2
Concord 2
Detroit 2
Guarulhos 2
Hai Bà Trưng 2
Totale 2.981
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 192
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases 185
The role of an immune checkpoint score in resected non-small cell lung cancer patients' prognosis 166
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 161
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 160
Electrolyte disorders in cancer patients: a systematic review 160
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 157
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 152
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 152
Managing hyponatremia in lung cancer: latest evidence and clinical implications 151
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 151
High CTLA-4 expression correlates with poor prognosis in thymoma patients 149
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 148
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 145
Systemic treatment for lung carcinoids: from bench to bedside 145
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 145
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 144
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 142
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 141
Hyponatremia in cancer patients: Time for a new approach 140
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 134
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 134
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 132
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 132
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 118
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 118
The Formidable Metamorphosis of the Salamander’s Wool: Asbestos from Eternal Material to Awful Pathologies 117
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 116
Lung cancer prognosis: Can histological patterns and morphological features have a role in the management of lung cancer patients? 114
Treatment of advanced small cell lung cancer 106
Totale 4.307
Categoria #
all - tutte 19.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022228 17 34 16 1 4 25 7 14 19 26 26 39
2022/2023622 34 86 36 72 20 113 0 43 142 0 61 15
2023/2024371 52 7 32 14 49 110 4 41 0 15 0 47
2024/2025603 84 49 16 3 36 31 56 26 102 37 79 84
2025/20261.568 145 77 54 212 196 139 267 153 106 131 26 62
Totale 4.307